会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 1. 发明公开
    • MEANS AND METHODS FOR DIAGNOSING A VIRAL INFECTION
    • EP4443159A1
    • 2024-10-09
    • EP23166965.6
    • 2023-04-06
    • Bruker BioSpin GmbH & Co. KGMurdoch University
    • Wist, JulienSala, SamueleNitschke, PhilippNicholson, Jeremy J.Holmes, ElaineTrautwein, ChristophCannet, Claire
    • G01N33/50C07F9/6558C07F9/6561G01N33/569G01N33/68
    • G01N33/6848G01N33/5091G01N33/56983G01N2333/16520130101C07H19/06
    • The invention relates to the field of viral diagnosis. In particular, it is directed to a method for diagnosing a viral infection or a disease associated therewith in a subject comprising the steps of: (a) determining in a sample of said subject the amount of at least one biomarker selected from the group of 3'(,5'-di)deoxy-3',4'-didehydro furanose derivatives of formula (I) with the exception of 3'-deoxy-3',4'-didehydro-cytidine (ddhC); and (b) comparing the amount(s) of the at least one biomarkers determined in (a) with a reference, thereby diagnosing a viral infection.
      Further, the invention is directed to a method for diagnosing a viral infection or a disease associated therewith in a subject comprising the steps of: (A) determining in a sample of said subject the amount of 3'-deoxy-3',4'-didehydro-cytidine (ddhC); and (B) comparing the amount of the ddhC determined in (A) with a reference, thereby diagnosing a viral infection;
      wherein the determination in (a) is done by NMR spectroscopy and the sample of the subject is a urine sample of said subject.
      The invention is also related to a diagnostic means for use in diagnosing a viral infection or a disease associated therewith, said diagnostic means comprising at least one biomarker selected from the group of 3'(,5'-di)deoxy-3',4'-didehydro furanose derivatives of formula (I) with the exception of 3'-deoxy-3',4'-didehydro-cytidine (ddhC), but also to a diagnostic means comprising 3'-deoxy-3',4'-didehydro-cytidine (ddhC) for use in diagnosing a viral infection or a disease associated therewith, wherein the amount of the biomarker is determined done by NMR spectroscopy in a urine sample of a subject.
      Furthermore, the invention is directed to a device for diagnosing a viral infection or a disease associated therewith in a sample of a subject and to a kit for identifying a subject suffering from a viral infection or a disease associated therewith.